Hyderabad: Covaxin, a vaccine candidate being developed by Bharat Biotech for COVID-19, can offer protection against mutations of Coronavirus, said Krishna Ella, Chairman and Managing Director of the city-based vaccine maker, on Tuesday.
He also said the company had approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology and now undergoing phase 3 trials.
